{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:34:41Z","timestamp":1793295281279,"version":"4.5.0"},"reference-count":72,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:00:00Z","timestamp":1679011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJNS"],"abstract":"<jats:p>In 1963, Robert Guthrie\u2019s pioneering work developing a bacterial inhibition assay to measure phenylalanine in dried blood spots, provided the means for whole-population screening to detect phenylketonuria in the USA. In the following decades, NBS became firmly established as a part of public health in developed countries. Technological advances allowed for the addition of new disorders into routine programmes and thereby resulted in a paradigm shift. Today, technological advances in immunological methods, tandem mass spectrometry, PCR techniques, DNA sequencing for mutational variant analysis, ultra-high performance liquid chromatography (UPLC), iso-electric focusing, and digital microfluidics are employed in the NBS laboratory to detect more than 60 disorders. In this review, we will provide the current state of methodological advances that have been introduced into NBS. Particularly, \u2018second-tier\u2019 methods have significantly improved both the specificity and sensitivity of testing. We will also present how proteomic and metabolomic techniques can potentially improve screening strategies to reduce the number of false-positive results and improve the prediction of pathogenicity. Additionally, we discuss the application of complex, multiparameter statistical procedures that use large datasets and statistical algorithms to improve the predictive outcomes of tests. Future developments, utilizing genomic techniques, are also likely to play an increasingly important role, possibly combined with artificial intelligence (AI)-driven software. We will consider the balance required to harness the potential of these new advances whilst maintaining the benefits and reducing the risks for harm associated with all screening.<\/jats:p>","DOI":"10.3390\/ijns9010015","type":"journal-article","created":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T02:29:59Z","timestamp":1679020199000},"page":"15","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Current State and Innovations in Newborn Screening: Continuing to Do Good and Avoid Harm"],"prefix":"10.3390","volume":"9","author":[{"given":"Giancarlo","family":"la Marca","sequence":"first","affiliation":[{"name":"Newborn Screening, Clinical Chemistry and Pharmacology Lab, IRCCS Meyer Children\u2019s University Hospital, 50139 Florence, Italy"},{"name":"Department of Experimental and Clinical Biomedical Sciences, University of Florence, 50139 Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1988-3088","authenticated-orcid":false,"given":"Rachel. S.","family":"Carling","sequence":"additional","affiliation":[{"name":"Biochemical Sciences, Viapath, Guys & St Thomas\u2019 NHSFT, London SE1 7EH, UK"},{"name":"GKT School of Medical Education, Kings College London, London SE1 1UL, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3592-2254","authenticated-orcid":false,"given":"Stuart. J.","family":"Moat","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry, Immunology & Toxicology, University Hospital Wales, Cardiff CF14 4XW, UK"},{"name":"School of Medicine, Cardiff University, University Hospital Wales, Cardiff CF14 4XW, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6789-1563","authenticated-orcid":false,"given":"Raquel","family":"Yahyaoui","sequence":"additional","affiliation":[{"name":"Laboratory of Metabolic Disorders and Newborn Screening Center of Eastern Andalusia, M\u00e1laga Regional University Hospital, Institute of Biomedical Research in Malaga (IBIMA-Plataforma BIONAND), Avenida Arroyo de los Angeles s\/n, 29011 Malaga, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enzo","family":"Ranieri","sequence":"additional","affiliation":[{"name":"Biochemical Genetics, Genetics and Molecular Pathology, SA Pathology, Women\u2019s & Children\u2019s Hospital, Adelaide 5043, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James. R.","family":"Bonham","sequence":"additional","affiliation":[{"name":"Sheffield Children\u2019s NHS Foundation Trust, Western Bank, Sheffield S10 2TH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5630-7322","authenticated-orcid":false,"given":"Peter. C. J. I.","family":"Schielen","sequence":"additional","affiliation":[{"name":"International Society for Neonatal Screening, Reigerskamp 273, 3607 HP Stichtse Vecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Loeber, J.G., Platis, D., Zetterstr\u00f6m, R.H., Almashanu, S., Boemer, F., Bonham, J.R., Borde, P., Brincat, I., Cheillan, D., and Dekkers, E. (2021). Neonatal Screening in Europe Revisited: An ISNS Perspective on the Current State and Developments Since 2010. Int. J. Neonatal Screen., 7.","DOI":"10.3390\/ijns7010015"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Padilla, C.D., Therrell, B.L., Panol, K.A.R., Suarez, R.C.N., Reyes, M.E.L., Jomento, C.M., Maceda, E.B.G., Lising, J.A.C., Beltran, F.D.E., and Orbillo, L.L. (2020). Philippine Performance Evaluation and Assessment Scheme (PPEAS): Experiences in Newborn Screening System Quality Improvement. Int. J. Neonatal Screen., 6.","DOI":"10.3390\/ijns6040095"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.15585\/mmwr.mm6936a6","article-title":"Infants with Congenital Disorders Identified Through Newborn Screening\u2014United States, 2015\u20132017","volume":"69","author":"Sontag","year":"2020","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/ajmg.c.31899","article-title":"Newborn screening in Latin America: A brief overview of the state of the art","volume":"187","author":"Borrajo","year":"2021","journal-title":"Am. J. Med. Genet. Part C Semin. Med. Genet."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1053\/j.semperi.2015.03.002","article-title":"Current status of newborn screening worldwide: 2015","volume":"39","author":"Therrell","year":"2015","journal-title":"Semin. Perinatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1542\/peds.32.3.338","article-title":"A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants","volume":"32","author":"Guthrie","year":"1963","journal-title":"Pediatrics"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0022-3476(76)80384-8","article-title":"TSH measurements from blood spots on filter paper: A confirmatory screening test for neonatal hypothyroidism","volume":"89","author":"Dussault","year":"1976","journal-title":"J. Pediatr."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1210\/jcem-55-3-413","article-title":"A Pilot Newborn Screening for Congenital Adrenal Hyperplasia in Alaska","volume":"55","author":"Pang","year":"1982","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0140-6736(79)90825-0","article-title":"Dried-blood spot screening for cystic fibrosis in the newborn","volume":"313","author":"Crossle","year":"1979","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1136\/bmj.308.6942.1469","article-title":"Neonatal screening for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis: Four years\u2019 experience","volume":"308","author":"Ranieri","year":"1994","journal-title":"BMJ"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jcf.2018.07.008","article-title":"Newborn blood spot screening for cystic fibrosis with a four-step screening strategy in the Netherlands","volume":"18","author":"Bouva","year":"2019","journal-title":"J. Cyst. Fibros."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1373\/clinchem.2007.087775","article-title":"Rapid 2nd-Tier Test for Measurement of 3-OH-Propionic and Methylmalonic Acids on Dried Blood Spots: Reducing the False-Positive Rate for Propionylcarnitine during Expanded Newborn Screening by Liquid Chromatography\u2013Tandem Mass Spectrometry","volume":"53","author":"Malvagia","year":"2007","journal-title":"Clin. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1373\/clinchem.2010.148957","article-title":"Determination of Total Homocysteine, Methylmalonic Acid, and 2-Methylcitric Acid in Dried Blood Spots by Tandem Mass Spectrometry","volume":"56","author":"Turgeon","year":"2010","journal-title":"Clin. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/BF00710283","article-title":"Acylcarnitines in amniotic fluid: Application to the prenatal diagnosis of propionic acidaemia","volume":"16","author":"Chace","year":"1993","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1093\/clinchem\/47.11.1945","article-title":"Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: A two-year summary from the New England Newborn Screening Program","volume":"47","author":"Zytkovicz","year":"2001","journal-title":"Clin. Chem."},{"key":"ref_16","first-page":"648","article-title":"Enhanced interpretation of newborn screening results without analyte cutoff values","volume":"14","author":"Marquardt","year":"2012","journal-title":"Anesthesia Analg."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/gim.2014.62","article-title":"Postanalytical tools improve performance of newborn screening by tandem mass spectrometry","volume":"16","author":"Hall","year":"2014","journal-title":"Genet. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jaci.2011.12.964","article-title":"The long quest for neonatal screening for severe combined immunodeficiency","volume":"129","author":"Buckley","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"19922","DOI":"10.1038\/s41598-021-99496-2","article-title":"Three years pilot of spinal muscular atrophy newborn screening turned into official program in Southern Belgium","volume":"11","author":"Boemer","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/ajmg.c.32003","article-title":"Georgia state spinal muscular atrophy newborn screening experience: Screening assay performance and early clinical outcomes","volume":"190","author":"Elkins","year":"2022","journal-title":"Am. J. Med. Genet. Part C Semin. Med. Genet."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/bmj.39470.643218.94","article-title":"Maximising benefit and minimising harm of screening","volume":"336","author":"Gray","year":"2008","journal-title":"BMJ"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4155\/bio-2019-0201","article-title":"Effect of blood volume on analytical bias in dried blood spots prepared for newborn screening external quality assurance","volume":"12","author":"Moat","year":"2020","journal-title":"Bioanalysis"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1373\/clinchem.2015.247668","article-title":"Effect of Dried Blood Spot Quality on Newborn Screening Analyte Concentrations and Recommendations for Minimum Acceptance Criteria for Sample Analysis","volume":"62","author":"George","year":"2016","journal-title":"Clin. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/clinchem\/46.1.126","article-title":"Recoveries of Phenylalanine from Two Sets of Dried Blood-Spot Reference Materials: Prediction from Hematocrit, Spot Volume, and Paper Matrix","volume":"46","author":"Adam","year":"2000","journal-title":"Clin Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1700362","DOI":"10.1002\/ejlt.201700362","article-title":"Estimation of the Volume of Blood in a Small Disc Punched from a Dried Blood Spot Card","volume":"120","author":"Hewawasam","year":"2017","journal-title":"Eur. J. Lipid Sci. Technol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cca.2022.08.005","article-title":"Evaluation of volumetric blood collection devices for the measurement of phenylalanine and tyrosine to monitor patients with phenylketonuria","volume":"535","author":"Carling","year":"2022","journal-title":"Clin. Chim. Acta"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/clinchem\/hvac070","article-title":"Improving Harmonization and Standardization of Expanded Newborn Screening Results by Optimization of the Legacy Flow Injection Analysis Tandem Mass Spectrometry Methods and Application of a Standardized Calibration Approach","volume":"68","author":"Carling","year":"2022","journal-title":"Clin. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Carling, R.S., John, C., Goddard, P., Griffith, C., Cowen, S., Hopley, C., and Moat, S.J. (2020). Evaluation of a Common Internal Standard Material to Reduce Inter-Laboratory Variation and Ensure the Quality, Safety and Efficacy of Expanded Newborn Screening Results When Using Flow Injection Analysis Tandem Mass Spectrometry with Internal Calibration. Int. J. Neonatal Screen., 6.","DOI":"10.3390\/ijns6040092"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Pickens, C.A., Sternberg, M., Seeterlin, M., De Jes\u00fas, V.R., Morrissey, M., Manning, A., Bhakta, S., Held, P.K., Mei, J., and Cuthbert, C. (2020). Harmonizing Newborn Screening Laboratory Proficiency Test Results Using the CDC NSQAP Reference Materials. Int. J. Neonatal Screen., 6.","DOI":"10.3390\/ijns6030075"},{"key":"ref_30","unstructured":"Food and Drug Administration (2018). Bioanalytical Method Validation Guidance for Industry, Food and Drug Administration. Guidance for Industry Bioanalytical Method Validation."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1515\/cclm-2019-1024","article-title":"Recommendation for performance verification of patient-based real-time quality control","volume":"58","author":"Loh","year":"2020","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1373\/clinchem.2019.305482","article-title":"Patient-Based Real-Time Quality Control: Review and Recommendations","volume":"65","author":"Badrick","year":"2019","journal-title":"Clin. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.clinbiochem.2014.12.016","article-title":"Changing the paradigm of laboratory quality control through implementation of real-time test results monitoring: For patients by patients","volume":"48","author":"Fleming","year":"2015","journal-title":"Clin. Biochem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1108\/IJHCQA-09-2012-0092","article-title":"Patient results and laboratory test accuracy","volume":"27","author":"Katayev","year":"2014","journal-title":"Int. J. Health Care Qual. Assur."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1210\/jc.2006-2890","article-title":"Newborn Screening for Congenital Adrenal Hyperplasia: Additional Steroid Profile using Liquid Chromatography-Tandem Mass Spectrometry","volume":"92","author":"Janzen","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1373\/clinchem.2003.027193","article-title":"Improved Specificity of Newborn Screening for Congenital Adrenal Hyperplasia by Second-Tier Steroid Profiling Using Tandem Mass Spectrometry","volume":"50","author":"Lacey","year":"2004","journal-title":"Clin. Chem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1373\/clinchem.2007.098434","article-title":"Second-Tier Test for Quantification of Alloisoleucine and Branched-Chain Amino Acids in Dried Blood Spots to Improve Newborn Screening for Maple Syrup Urine Disease (MSUD)","volume":"54","author":"Oglesbee","year":"2008","journal-title":"Clin. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1258\/acb.2011.010283","article-title":"An improved ultra performance liquid chromatography-tandem mass spectrometry method for the determination of alloisoleucine and branched chain amino acids in dried blood samples","volume":"48","author":"Alodaib","year":"2011","journal-title":"Ann. Clin. Biochem. Int. J. Biochem. Lab. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e160012","DOI":"10.1177\/2326409816661355","article-title":"Reducing the False-Positive Rate for Isovalerylcarnitine in Expanded Newborn Screening","volume":"4","author":"Poggiali","year":"2016","journal-title":"J. Inborn Errors Metab. Screen."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Tangeraas, T., S\u00e6ves, I., Klingenberg, C., J\u00f8rgensen, J., Kristensen, E., Gunnarsdottir, G., Hansen, E.V., Strand, J., Lundman, E., and Ferdinandusse, S. (2020). Performance of Expanded Newborn Screening in Norway Supported by Post-Analytical Bioinformatics Tools and Rapid Second-Tier DNA Analyses. Int. J. Neonatal Screen., 6.","DOI":"10.3390\/ijns6030051"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Lund, A.M., Wibrand, F., Skogstrand, K., B\u00e6kvad-Hansen, M., Gregersen, N., Andresen, B.S., Hougaard, D.M., Dun\u00f8, M., and Olsen, R.K.J. (2021). Use of Molecular Genetic Analyses in Danish Routine Newborn Screening. Int. J. Neonatal Screen., 7.","DOI":"10.3390\/ijns7030050"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Gelb, M.H., Basheeruddin, K., Burlina, A., Chen, H.-J., Chien, Y.-H., Dizikes, G., Dorley, C., Giugliani, R., Hietala, A., and Hong, X. (2022). Liquid Chromatography\u2013Tandem Mass Spectrometry in Newborn Screening Laboratories. Int. J. Neonatal Screen., 8.","DOI":"10.3390\/ijns8040062"},{"key":"ref_43","unstructured":"Ranieri, E. (2022, January 16\u201320). Neonatal Screening for Peroxisomal Disorders: New and Novel Lipid Biomakers. Proceedings of the APHL-Newborn Screening Symposium, Tacoma, WA, USA."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1021\/acs.jproteome.1c00775","article-title":"Targeted Metabolomics Reveals Birth Screening Biomarkers for Biliary Atresia in Dried Blood Spots","volume":"21","author":"Xiao","year":"2022","journal-title":"J. Proteome Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1007\/s12031-020-01787-2","article-title":"Studying Autism Using Untargeted Metabolomics in Newborn Screening Samples","volume":"71","author":"Courraud","year":"2021","journal-title":"J. Mol. Neurosci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1021\/acs.jproteome.0c00031","article-title":"Dried Blood Spot-Based Metabolomic Profiling in Adults with Cystic Fibrosis","volume":"19","author":"Jabar","year":"2020","journal-title":"J. Proteome Res."},{"key":"ref_47","first-page":"841","article-title":"Metabolic Signatures of Cystic Fibrosis Identified in Dried Blood Spots for Newborn Screening Without Carrier Identification","volume":"18","author":"DiBattista","year":"2018","journal-title":"J. Proteome Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"165725","DOI":"10.1016\/j.bbadis.2020.165725","article-title":"Prediction of VLCAD deficiency phenotype by a metabolic fingerprint in newborn screening bloodspots","volume":"1866","author":"Knottnerus","year":"2020","journal-title":"Biochim. Biophys. Acta (BBA)\u2014Mol. Basis Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/MOP.0000000000000875","article-title":"Metabolomics and adductomics of newborn bloodspots to retrospectively assess the early-life exposome","volume":"32","author":"Petrick","year":"2020","journal-title":"Curr. Opin. Pediatr."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"109543","DOI":"10.1016\/j.mehy.2019.109543","article-title":"Newborn metabolomic profile mirrors that of mother in pregnancy","volume":"137","author":"Perrone","year":"2020","journal-title":"Med. Hypotheses"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jpeds.2014.10.021","article-title":"Lipidomic analyses, breast- and formula-feeding and growth in infants","volume":"166","author":"Prentice","year":"2015","journal-title":"J. Pediatr."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1080\/14789450.2019.1654863","article-title":"Postnatal gestational age estimation via newborn screening analysis: Application and potential","volume":"16","author":"Wilson","year":"2019","journal-title":"Expert Rev. Proteom."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"13067","DOI":"10.1038\/s41598-019-49685-x","article-title":"NMR-based newborn urine screening for optimized detection of inherited errors of metabolism","volume":"9","author":"Embade","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"17094","DOI":"10.1021\/acs.analchem.1c04267","article-title":"Improving the Speed and Selectivity of Newborn Screening Using Ion Mobility Spectrometry\u2013Mass Spectrometry","volume":"93","author":"Dodds","year":"2021","journal-title":"Anal. Chem."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.3389\/fimmu.2018.02756","article-title":"Rapid Multiplexed Proteomic Screening for Primary Immunodeficiency Disorders from Dried Blood Spots","volume":"9","author":"Collins","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Naubourg, P., El Osta, M., Rageot, D., Grunewald, O., Renom, G., Ducoroy, P., and P\u00e9rini, J.-M. (2019). A Multicentre Pilot Study of a Two-Tier Newborn Sickle Cell Disease Screening Procedure with a First Tier Based on a Fully Automated MALDI-TOF MS Platform. Int. J. Neonatal Screen., 5.","DOI":"10.3390\/ijns5010010"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3389\/fimmu.2020.00464","article-title":"Multiplexed Proteomic Analysis for Diagnosis and Screening of Five Primary Immunodeficiency Disorders from Dried Blood Spots","volume":"11","author":"Collins","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3389\/fimmu.2020.00455","article-title":"Newborn screening for presymptomatic diagnosis of complement and phagocyte deficiencies","volume":"11","author":"Dezfouli","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.clinms.2019.03.002","article-title":"Rapid method towards proteomic analysis of dried blood spots by MALDI mass spectrometry","volume":"12","author":"Samenuk","year":"2019","journal-title":"Clin. Mass Spectrom."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/GIM.0b013e31820d5e67","article-title":"Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: A worldwide collaborative project","volume":"13","author":"McHugh","year":"2011","journal-title":"Genet. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2471\/BLT.07.050112","article-title":"Revisting wilson and Jungner in the genomic age: A review of screening criteria over the past 40 years","volume":"86","author":"Andermann","year":"2008","journal-title":"Bull. World Health Organ."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"16266","DOI":"10.1073\/pnas.0808319105","article-title":"Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood","volume":"105","author":"Fan","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Veldman, A., Kiewiet, M.B.G., Heiner-Fokkema, M.R., Nelen, M.R., Sinke, R.J., Sikkema-Raddatz, B., Voorhoeve, E., Westra, D., Doll\u00e9, M.E.T., and Schielen, P.C.J.I. (2022). Towards Next-Generation Sequencing (NGS)-Based Newborn Screening: A Technical Study to Prepare for the Challenges Ahead. Int. J. Neonatal Screen., 8.","DOI":"10.3390\/ijns8010017"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jaci.2020.10.020","article-title":"SCID newborn screening: What we\u2019ve learned","volume":"147","author":"Currier","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3343\/alm.2023.43.3.280","article-title":"Rapid Targeted Sequencing Using Dried Blood Spot Samples for Patients with Suspected Actionable Genetic Diseases","volume":"43","author":"Kim","year":"2022","journal-title":"Ann. Lab. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.3389\/fimmu.2020.01417","article-title":"Second-Tier Next Generation Sequencing Integrated in Nationwide Newborn Screening Provides Rapid Molecular Diagnostics of Severe Combined Immunodeficiency","volume":"11","author":"Strand","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_67","first-page":"337","article-title":"Development of DNA Confirmatory and High-Risk Diagnostic Testing for Newborns Using Targeted Next-Generation DNA Sequencing","volume":"17","author":"Bhattacharjee","year":"2015","journal-title":"Anesthesia Analg."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/s41591-020-0966-5","article-title":"The role of exome sequencing in newborn screening for inborn errors of metabolism","volume":"26","author":"Adhikari","year":"2020","journal-title":"Nat. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ajhg.2018.11.016","article-title":"Interpretation of Genomic Sequencing Results in Healthy and Ill Newborns: Results from the BabySeq Project","volume":"104","author":"Murry","year":"2019","journal-title":"Am. J. Hum. Genet."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Kinsella, S., Hopkins, H., Cooper, L., and Bonham, J.R. (2022). A Public Dialogue to Inform the Use of Wider Genomic Testing When Used as Part of Newborn Screening to Identify Cystic Fibrosis. Int. J. Neonatal Screen., 8.","DOI":"10.3390\/ijns8020032"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"100311","DOI":"10.1016\/j.lanepe.2022.100311","article-title":"Newborn screening as a fully integrated system to stimulate equity in neonatal screening in Europe","volume":"13","author":"Scarpa","year":"2022","journal-title":"Lancet Reg. Health Eur."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Sikonja, J., Groselj, U., Scarpa, M., la Marca, G., Cheillan, D., K\u00f6lker, S., Zetterstr\u00f6m, R.H., Ko\u017eich, V., Le Cam, Y., and Gumus, G. (2022). Towards Achieving Equity and Innovation in Newborn Screening across Europe. Int. J. Neonatal Screen., 8.","DOI":"10.3390\/ijns8020031"}],"container-title":["International Journal of Neonatal Screening"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2409-515X\/9\/1\/15\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:57:15Z","timestamp":1760122635000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2409-515X\/9\/1\/15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,17]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["ijns9010015"],"URL":"https:\/\/doi.org\/10.3390\/ijns9010015","relation":{},"ISSN":["2409-515X"],"issn-type":[{"value":"2409-515X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,17]]}}}